Home>>Signaling Pathways>> Ox Stress Reagents>> Pro-Oxidant Activity>>9,10-Anthracenediyl-bis(methylene)dimalonic Acid

9,10-Anthracenediyl-bis(methylene)dimalonic Acid (Synonyms: ABMDMA)

Catalog No.GC42642

9,10-Anthracenediyl-bis(methylene)dimalonic acid (ABMDMA) is a reagent used to detect singlet oxygen generation.

Products are for research use only. Not for human use. We do not sell to patients.

9,10-Anthracenediyl-bis(methylene)dimalonic Acid Chemical Structure

Cas No.: 307554-62-7

Size Price Stock Qty
50mg
$89.00
In stock
100mg
$169.00
In stock
250mg
$402.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Description Protocol Chemical Properties Product Documents Related Products

9,10-Anthracenediyl-bis(methylene)dimalonic acid (ABMDMA) is a reagent used to detect singlet oxygen generation. This water-soluble derivative of anthracene can be photobleached by singlet oxygen to its corresponding endoperoxide. This reaction can be monitored spectrophotometrically by recording the decrease in optical density at 400 nm (ABMDMA ex/em max. = 380/407 nm in 0.1 M phosphate pH 7.0).[1]

Reference:
[1]. Katayama, Y., and Mori, A. Inhibitory action of (3R)-(−)-4-amino-3-hydroxybutanoic acid on N-amidinobenzamide induced seizure activity in cat brain. IRCS Med. Sci. 5, 437 (1977).

Reviews

Review for 9,10-Anthracenediyl-bis(methylene)dimalonic Acid

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 9,10-Anthracenediyl-bis(methylene)dimalonic Acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.